India: Of Bad Drugs, Deaths And Promises Of Reforms
This article was originally published in PharmAsia News
Executive Summary
The recent deaths of 13 women due to contaminated ciprofloxacin administered at a sterilization camp in India, is being seen as a wake-up call for regulators - to both accept shortcomings and chart out a serious plan for regulatory overhaul.